Clinical Trials Directory

Trials / Completed

CompletedNCT02579915

Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC)

Phase 2 Randomized Controlled Trial of Attention and Interpretation Modification (AIM) for Anxiety Disorders in Primary Care

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Brown University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to develop a personalized, user-friendly computerized treatment for anxiety disorders linked to primary care. The computerized treatment is a type of Cognitive Bias Modification, which targets attention and interpretation biases known to maintain anxiety disorders.

Detailed description

The primary goals of our 3-year, 2-phase project are to develop AIM for primary care linkage and assess its feasibility and acceptability. This protocol description only pertains to Phase 2 (Randomized Controlled Trial). 42 primary care patients with primary Generalized Anxiety Disorder, Social Anxiety Disorder, and/or Panic Disorder (with or without Agoraphobia) will be randomly assigned to the AIM treatment or to a symptom tracking control group. Full assessments will occur pre- and post-treatment and 3-months follow-up. A mid-treatment assessment will include measures of cognitive biases and the primary outcome. Weekly measures of anxiety and depression will be collected, as will feedback from patients and PCPs about the research and delivery procedures.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFaceAnxietyComputerized treatment targeting mental habits and primary care linkage.
BEHAVIORALSymptom TrackingWeekly self-assessment with validated questionnaires and primary care linkage

Timeline

Start date
2015-09-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2015-10-20
Last updated
2020-02-07
Results posted
2020-02-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02579915. Inclusion in this directory is not an endorsement.